Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ceapro Inc V.CZO

Alternate Symbol(s):  CRPOF

Chemicals Specialty Chemicals
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

Recent & Breaking News (TSXV:CZO)

Ceapro Inc. Reports First Quarter 2015 Financial and Operations Results

Marketwired June 1, 2015

Ceapro to Develop Enabling Pressurized Gas Expanded Technology (PGX) at Commercial and Demonstration Scale

Marketwired May 28, 2015

Ceapro Announces Appointment of New Chief Financial Officer

Marketwired May 5, 2015

Ceapro Appoints Seasoned Pharmaceutical Industry Executive, Ulrich Kosciessa, Ph.D., to its Board of Directors

Marketwired April 28, 2015

Ceapro Reports Record Full-Year 2014 Financial Results

Marketwired April 22, 2015

Ceapro Expands License Agreement With University of Alberta for PGX Technology

Marketwired February 11, 2015

Ceapro Raises an Additional $310,000 Through a Non-Brokered Private Placement

Marketwired February 4, 2015

Ceapro Raises $650,000 through a Non-Brokered Private Placement

Marketwired January 21, 2015

Ceapro to Present at the Eighth Annual OneMedForum on Tuesday, January 13, 2015

Marketwired January 8, 2015

Ceapro Announces Grant of Stock Options

Marketwired January 7, 2015

Ceapro Enters into Financing Agreement with Agriculture Financial Services Corporation

Marketwired December 18, 2014

Ceapro Awarded Research Grant from Alberta Innovates Bio Solutions to Develop Novel Formulations for Energy Drink

Marketwired December 4, 2014

Ceapro's Research Scientist, Bernhard Seifried, Ph.D., Honored with Scientific Achievement & Innovation Award from BioAlberta

Marketwired November 26, 2014

Ceapro Appoints World Renowned Health and Disease Management Expert, William W. Li, M.D. to Board of Directors

Marketwired November 20, 2014

Ceapro Inc. Reports Third Quarter 2014 Financial Results

Marketwired November 14, 2014

Ceapro Engages Jenene Thomas Communications, LLC as Strategic Investor Relations and Corporate Communications Advisor

Marketwired November 13, 2014

TakeStock Alberta Investor Forum - Calgary, Alberta - November 5th, 2014 - Video News Alert on Investmentpitch.com

Newsfile November 4, 2014

Ceapro Announces Change of Chairman of the Board

Marketwired October 3, 2014

SeeThruEquity Fall Microcap Investor Conference To Be Held September 11, 2014

Accesswire September 8, 2014

Ceapro Reports Record Second Quarter 2014 Financial Results

Marketwired July 30, 2014